The hygiene hypothesis and multiple sclerosis

Annals of Neurology

Volumn 61, Issue 2, 2007, Pages 85-89

  Fleming, John ^a   Fabry, Zsuzsanna ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; DISEASE SEVERITY; EDITORIAL; EOSINOPHILIA; HOST PATHOGEN INTERACTION; HUMAN; HYGIENE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INCIDENCE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RELAPSE; TH1 CELL; TH2 CELL;

AUTOIMMUNE DISEASES; HUMANS; HYGIENE; HYPERSENSITIVITY; MODELS, BIOLOGICAL;

EID: 33847639785     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21092     Document Type: Editorial

References (67)

1. Holgate ST. The epidemic of allergy and asthma. Nature 1999;402(suppl 1):B2-B4.
2. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopath 1997;84:223-243.
3. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-931.
4. Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002;51:3353-3361.
5. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002;296:490-494.
6. Strachan DP. Hay fever, hygiene, and household size. Br Med J 1989;299:1259-1260.
7. Leibowitz U, Antonovsky A, Medalie JM, et al. Epidemiological study of multiple sclerosis in Israel. II. multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatry 1966;29:60-68.
8. Bach JF. Infections and autoimmune diseases. J Autoimmun 2005;25(suppl):74-80.
9. Cooke A, Zaccone P, Raine T, et al. Infection and autoimmunity: are we winning war, only to lose the peace? Trends Parasitol 2004;20:316-321.
10. Elias D, Wolday D, Akuffo H, et al. Effect of deworming on human T cell responses to myobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin Exp Immunol 2001;123:219-225.
11. McKay DM. The beneficial helminth parasite? Parasitology 2006;132:1-12.
12. Nyan OA, Walraven GE, Banya WA, et al. Atopy, intestinal helminth infection and total setum IgE in rural and urban adult Gambian communities. Clin Exp Allergy 2001;31:1672-1678.
13. Maizels RM. Infection and allergy helminths-hygiene and host immune regulation. Curr Opin Immunol 2005;17:656-661.
14. Vercelli D. Mechanisms of the hygiene hypothesis-molecular and otherwise. Curr Opin Immunol 2006;18:733-737.
15. Yazdankbakhsh M, Matricardi PM. Parasites and the hygiene hypothesis: regulating the immune system? Clin Rev Allergy Immunol 2004;26:15-24.
16. Zaccone P, Fehervari Z, Phillips JM, et al. Parasitic worms and inflammatory diseases. Parasite Immunol 2006;28:515-523.
17. Boitelle A, Scales HE, Di Lorenzo C, et al. Investigating the impact of helminth products on immune responsiveness using a TCR transgenic adoptive transfer system. J Immunol 2003;171:447-454.
18. Elliott DE, Li J, Blum A, et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003;284:G385-G391.
19. Fox JG, Beck P, Dangler CA, et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced gastric atrophy. Nat Med 2000;6:536-542.
20. Kitagaki K, Businga TR, Racilia D, et al. Intestinal helminths protect in a murine model of asthma. J Immunol 2006;177:1628-1635.
21. Saunders KA, Raine T, Cooke A, et al. Inhibition of type 1 diabetes by gastrointestinal helminth infection. Infect Immun 2007;75:397-407.
22. Wohlleben G, Trujillo C, Muller J, et al. Helminth infection modulates the development of allergen-induced airway inflammation. Int Immunol 2004;16:585-596.
23. Floch MH, Montrose DC. Use of probiotics in humans: an analysis of the literature. Gastroenterol Clin N Am 2005;34:547-570.
24. Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the 'hygiene hypothesis': too clean to be true? Br J Derm 2005;152:202-216.
25. Summers RW, Elliott DE, Urban JF Jr, et al. Trichuris suis therapy in Crohn's disease. Gut 2005;54:87-90.
26. Summers RW, Elliott DE, Urban JF Jr, et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005;128:825-832.
27. Baecher-Allan C, Hafler DA. Human regulatory T cells and their role in autoimmune disease. Immunol Rev 2006;212:203-216.
28. + regulatory T cells and their therapeutic potential. Annu Rev Med 2006;57:381-402.
29. Wing K, Sakaguchi S. Regulatory T cells as potential immunotherapy in allergy. Curr Opin Allergy Clin Immunol 2006;6:482-488.
30. Harnett W, Harnett MM. Filarial nematode secreted product ES-62 is an anti-inflammatory agent: therapeutic potential of small molecule derivatives and ES-62 peptide mimetics. Clin Exp Pharm Physiol 2006;33:511-518.
31. Wilson MS, Taylor MD, Balic A, et al. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 2005;202:1199-1212.
32. Buljevac D, Flach HZ, Hop WC, et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002;125:952-960.
33. Correale J, Fiol M, Gilmore W. The risk of relapses in multiple sclerosis during systemic infections. Neurology 2006;67:652-659.
34. Gilden DH. Infectious causes of multiple sclerosis. Lancet Neurol 2005;4:195-202.
35. Goverman J, Woods A, Larson L, et al. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993;72:551-560.
36. Fallon PG, Alcami A. Pathogen-derived immunomodulatory molecules: future immunotherapeutics? Trends Immunol 2006;27:470-476.
37. Sewell DL, Reinke EK, Hogan LH, et al. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol Lett 2002;82:101-110.
38. Sewell D, Qing Z, Reinke E, et al. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 2003;15:59-69.
39. La Flamme AC, Ruddenklau K, Backstrom BT. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 2003;71:4996-5004.
40. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994;78:399-408.
41. Fleming JO, Cook TD. Multiple sclerosis and the hygiene hypothesis. Neurology 2006;67:2085-2086.
42. Ponsonby AL, van der Mei I, Dwyer T, et al. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA 2005;293:463-469.
43. Ponsonby AL, Dwyer T, van der Mei I, et al. Asthma onset prior to multiple sclerosis and the contribution of sibling exposure in early life. Clin Exp Immunol 2006;146:463-470.
44. Cabre P, Signate A, Olindo S, et al. Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain 2005;128:2899-2910.
45. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DL. Loss of functional suppression by CD4+CD5+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004;199:971-979.
46. Correale J, Farez M. Parasite infections modulate the immune response in multiple sclerosis. Ann Neurol 2007;61:97-108.
47. Gopinath R, Keystone JS. Ascariasis, trichuriasis, and enterobiasis. In: Blaser MJ, Smith PD, Ravdin JI, et al., eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995:1167-1177.
48. Liu LX, Weller PF. Intestinal nematodes. In: Rustgi VK, ed. Gastrointestinal infections in the tropics. Basel: Karger, 1990:145-169.
49. Lassmann H, Ransohoff RM. The CD4-Th1 model for multiple sclerosis: a critical re-appraisal. Trends Immunol 2004;25:132-137.
50. Tremlett HL, Evans J, Wiles CM, Luscombe DK. Asthma and multiple sclerosis: an inverse association in a case-control general practice population. Q J Med 2002;95:753-756.
51. Amre DK, Lambrette P, Law L, et al. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study. Am J Gastroenterol 2006;101:1005-1011.
52. Cooper PJ, Chico ME, Vaca MG, et al. Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geoheminth parasites: cluster-randomized trial. Lancet 2006;367:1598-1603.
53. Sadovnick AD, Yee IML, Ebers GC. Multiple sclerosis and birth order: a longitudinal cohort study. Lancet Neurol 2005;4:611-617.
54. van Schayck CP, Knottnerus JA. No clinical evidence base to support the hygiene hypothesis. Prim Care Respir J 2004;13:76-79.
55. Sheikh A, Strachan DP. The hygiene theory: fact or fiction? Curr Opin Otolaryngol Head Neck Surg 2004;12:232-236.
56. Dunne DW, Cooke A. A worm's eye view of the immune system: consequences for the evolution of human autoimmune disease. Nat Rev Immunol 2005;5:420-426.
57. Summers RW, Elliott DE, Qadir K, et al. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 2003;98:2034-2041.
58. Summers RW, Elliott DE, Weinstock JV. Why Trichuris suis should prove safe for use in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:783-784.
59. Hokke CH, Yazdanbakhsh M. Schistosome glycans and innate immunity. Parasite Immunol 2005;27:257-264.
60. Thomas PG, Harn DA. Immune biasing by helminth glycans. Cell Microbiol 2004;6:13-22.
61. Rzepecka J, Lucius R, Doligalska M, et al. Screening for immunodulatory proteins of the intestinal parasitic nematode Heligmosomoides polygyrus. Parasite Immunol 2006;28:463-472.
62. Ruby E, Henderson B, McFall-Ngai M. We get by with a little help from our (little) friends. Science 2004;303:1305-1307.
63. McFall-Ngai M. Love the one you're with: vertebrate guts shape their microbiota. Cell 2006;127:247-249.
64. Woolhouse MEJ, Webster JP, Domingo E, et al. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat Genet 2002;32:569-577.
65. Van Kruiningen HJ, West AB. Potential danger in the medical use of Trichuris suis for the treatment of inflammatory bowel disease. Inflamm Bowel Dis 2005;11:515.
66. Kradin RL, Badizadegan K, Auluck P, et al. Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch Pathol Lab Med 2006;130:718-720.
67. Summers RW, Elliott DE, Weinstock JV. Therapeutic colonization with Trichuris suis. Arch Pathol Lab Med 2006;130:1753-1754.